Furthermore, mTOR regulates the expression of survival factors in cancer cells, such as cellular myelocytomatosis (C-MYC), and hypoxia induced gene 1 (HIG1), as well as angiogenic factors, including vascular endothelial growth factor (VEGF) [52–55]. This evidence concerns the gene VEGFA and cancer.